Swan, Alicia A <br/><br/>
Preclinical efficacy testing in middle-aged rats: nicotinamide, a novel neuroprotectant, demonstrates diminished preclinical efficacy after controlled cortical impact.  [electronic resource] 

 -  Journal of neurotrauma  Mar 2011 
 - 431-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1557-9042 
<br/><br/><label>Standard No.: </label>10.1089/neu.2010.1519  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Analysis of Variance<br/>Animals<br/>Astrocytes--drug effects<br/>Blood-Brain Barrier--drug effects<br/>Brain Edema--drug therapy<br/>Brain Injuries--drug therapy<br/>Cerebral Cortex--drug effects<br/>Cognition--drug effects<br/>Glial Fibrillary Acidic Protein--metabolism<br/>Immunohistochemistry<br/>Male<br/>Maze Learning--drug effects<br/>Motor Activity--drug effects<br/>Niacinamide--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Recovery of Function--drug effects<br/>Vitamin B Complex--pharmacology